Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 320 results found. Search for [ oxford covid vaccine ]

Results 1 to 21 of 320
Joe C Mathew
September 30, 2020
They state that access to means to fight COVID-19 on a global scale requires financial resources, assets, infrastructure, and jurisdictional support and collaboration beyond the capacity or role of each one of them


BusinessToday.In
September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing


PTI
September 27, 2020
British Prime Minister Boris Johnson made a special reference to India's role in the manufacture and access to one of the most promising coronavirus vaccine candidates currently undergoing trials during his address to the United Nations (UN) General Assembly


BusinessToday.In
September 27, 2020
Adar Poonawalla had earlier expressed concerns around production and distribution plans of the coronavirus vaccine. He asked if the Centre had Rs 80,000 crore available with it over next one year to distribute vaccine to Indians


BusinessToday.In
September 26, 2020
Adar Poonawalla, CEO of the Serum Institute of India (SII), on Saturday expressed his concerns around production and distribution of coronavirus vaccine in the country


BusinessToday.In
New Delhi, September 23, 2020
Adar Poonawalla is the CEO of his family-owned company Serum Institute of India, which is the world's largest manufacturer of vaccines by volume. Poonawalla, who is in the spotlight in the global vaccine race for coronavirus, has promised to manufacture 400 million doses per month after the approval of the coronavirus vaccine. He has become the biggest hope for the global community during the pandemic. Serum Institute is currently conducting phase 3 clinical trials for the Oxford University-AstraZeneca vaccine. Here is all you need to know about the man himself and how he might prove to be our best bet during the pandemic. Watch the video for more.Also Read: Serum Institute to conduct clinical trials for Novavax COVID-19 vaccine


BusinessToday.In
September 23, 2020
Pharma giant Johnson & Johnson (J&J) has started a massive global phase 3 clinical trial with 60,000 people of its single-dose coronavirus vaccine


BusinessToday.In
September 23, 2020
This inoculation adds to Bharat Biotech's portfolio of vaccines currently being developed by it and are in several stages of clinical development, comprising COVAXIN- which is India's first indigenous vaccine against coronavirus


BusinessToday.In
September 22, 2020
Gagandeep Kang, professor of microbiology at Christian Medical College said that by year-end, data on which vaccine candidate is working and which not will be made available


BusinessToday.In
New Delhi, September 21, 2020
Farm bills passed in Rajya Sabha amid protests by opposition MPs; Tata Consultancy Services sets up 11 COVID-19 isolation centres for staff, dependents; DCGI nod to commercial launch of India's first low-cost COVID-19 test 'FELUDA'. Watch this and more news on News Blast.Also Read: Feluda: Satyajit Ray's iconic character who is now COVID-19 detective


Rashi Bisaria
New Delhi, September 21, 2020
Farm bills passed in Rajya Sabha amid protests by opposition MPsThe Rajya Sabha has passed the Farmers' and Produce Trade and Commerce (Promotion and Facilitation) Bill, 2020 and Farmers (Empowerment and Protection) Agreement on Price Assurance and Farm Services Bill, 2020, through voice vote amid protest by opposition MPs and farmers' protests across Punjab and Haryana. The bills were passed in the Lok Sabha last week.Tata Consultancy Services sets up 11 COVID-19 isolation centres for staf...


BusinessToday.In
September 20, 2020
AstraZeneca's trial blueprint says that its goal is to develop a vaccine with 50 per cent effectiveness


BusinessToday.In
September 19, 2020
The final clinical trial of coronavirus vaccine by Oxford University and being manufactured by the Serum Institute of India (SII) will begin at the Sassoon General Hospital in Pune from Monday


Reuters
September 18, 2020
The decision by one of the U.N. agency's biggest supporters is a big blow to its strategy aimed at uniting governments around the world to fight the coronavirus pandemic together


BusinessToday.In
September 17, 2020
Addressing the Rajya Sabha over the coronavirus situation in the country, Dr. Harsh Vardhan said that India is also making efforts like other nations, adding that \"three vaccine candidates are in different phases\" of clinical trials


Rajeev Dubey, Dipak Mondal and Joe C Mathew
New Delhi, September 17, 2020
With GDP contracting 24 per cent in first quarter, economic recovery will be a long and painful process. Business Today's Rajeev Dubey, Dipak Mondal and Joe C. Mathew caught up with Chief Economic Advisor Krishnamurthy Subramanian on the state of the economy and plans to put it back on track. Edited excerpts:


BusinessToday.In
September 17, 2020
Adar Poonawalla-helmed Serum Institute had partnered with Novavax in August for the production of its coronavirus vaccine. The US drug developer plans to manufacture 2 billion doses annually


BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


BusinessToday.In
September 16, 2020
Former Wipro CEO and Managing Director Abidali Neemuchwala has joined Dallas Venture Partners (DVP) as a venture partner


Reuters
September 16, 2020
China launched a vaccine emergency use programme in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech


PAGES 1 OF 16  12345